EOB-DTPA

CAS No. 158599-72-5

EOB-DTPA( —— )

Catalog No. M36120 CAS No. 158599-72-5

EOB-DTPA is a biochemical reagent that can be synthesized from other compounds and is commonly used in MRI.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 698 Get Quote
10MG 938 Get Quote
25MG 1422 Get Quote
50MG 1822 Get Quote
100MG 2502 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EOB-DTPA
  • Note
    Research use only, not for human use.
  • Brief Description
    EOB-DTPA is a biochemical reagent that can be synthesized from other compounds and is commonly used in MRI.
  • Description
    EOB-DTPA is a biochemical reagent that can be synthesized from other compounds and is commonly used in MRI.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    158599-72-5
  • Formula Weight
    527.52
  • Molecular Formula
    C23H33N3O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](N(CC(O)=O)CC(O)=O)(CC1=CC=C(OCC)C=C1)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Fenpyroximate

    Fenpyroximate is an acaricide and insecticide. It blocks the mitochondrial electron transport in complex I.

  • SMA-12b

    SMA-12b is an analog of the immunomodulatory parasite product ES-62 that has immunomodulatory activity, can modify the expression of many inflammatory response genes.

  • FIDAS-5

    FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding.?FIDAS-5 has anticancer activities.?FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM.FIDAS-5 induces the expression of cell cycle inhibitor, p21WAF1/CIP1. FIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells.FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells.